Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jan 13;13:1062067. doi: 10.3389/fimmu.2022.1062067

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2023 Maaske, Sproule, Falsey, Sobieszczyk, Luetkemeyer, Paulsen, Riddler, Robb, Rolle, Sha, Tong, Ahani, Aksyuk, Bansal, Egan, Jepson, Padilla, Patel, Shoemaker, Stanley, Swanson, Wilkins, Villafana, Green and Kelly

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

AZD1222 vaccinees had an overall lower incidence and shorter duration of COVID-19 symptoms compared with placebo recipients upon symptomatic SARS-CoV-2 infection. (A) Incidence and (B) mean duration of self-reported COVID-19 symptoms recorded in participant e-Diaries during the 28-day illness period. (A) Symptoms with differences of ≤1.5% between arms were excluded from this plot. (B) Symptoms with differences in mean durations of ≤1 day between arms are excluded from this plot. Error bars depict standard deviation.